Page last updated: 2024-12-10

n,n-dimethylsphingenine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-dimethylsphingosine: a sphingosine kinase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N,N-dimethylsphingosine : A sphingoid that is sphingosine in which the two amino hydrogens are replaced by methyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282309
CHEMBL ID322333
CHEBI ID78759
SCHEMBL ID121927
SCHEMBL ID5493697
MeSH IDM0175296

Synonyms (53)

Synonym
n,n-dimethyl-erythro-sphingosine
d-erythro-n,n-dimethylsphingosine
n,n-dimethylsphingenine
n,n-dimethyl-d-erythrosphingenine
4-octadecene-1,3-diol, 2-(dimethylamino)-, (r-(r*,s*-(e)))-
n,n-dimethylsphing-4-enine
IDI1_033890
SMP2_000223
n,n-dimethylsphingosine
LMSP01070001
BSPBIO_001420
NCGC00161359-02
NCGC00161359-01
c20h41no2
NCGC00161359-03
HMS1989G22
bdbm50240721
(e)-(2s,3r)-2-dimethylamino-octadec-4-ene-1,3-diol
n,n-dimethyl-d-erythro-sphingosine
119567-63-4
CHEMBL322333 ,
chebi:78759 ,
n,n-dimethylspingosine
dimethylspingosine
BML3-C12
HMS1791G22
HMS1361G22
(e,2s,3r)-2-(dimethylamino)octadec-4-ene-1,3-diol
SL-105
SCHEMBL121927
SCHEMBL5493697
(2s,3r,4e)-2-(dimethylamino)octadec-4-ene-1,3-diol
(2s,3r,4e)-2-(dimethylamino)-4-octadecene-1,3-diol
2s-(dimethylamino)-4e-octadecene-1,3r-diol
YRXOQXUDKDCXME-YIVRLKKSSA-N
HB0237
AKOS024458272
HMS3649E19
HMS3402G22
J-004152
n,n-dimethylsphingosine, >=98% (hplc)
(s-(r,s-(e)))-2-(dimethylamino)-4-octadecene-1,3-diol
n,n-dimethyl-d-erythro-sphingosine]
dimethyl sphingosine (d18:1), n,n-dimethyl-d-erythro-sphingosine, chloroform
n-dimethylsphingosine
Q27147941
SR-01000946568-1
sr-01000946568
NCGC00161359-04
4-octadecene-1,3-diol, 2-(dimethylamino)-, (2s,3r,4e)-
dms, sk inhibitor iii, sphingosine kinase inhibitor iii
CS-0028981
HY-108491

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"To study the effect of the sphingosine kinase 1 (SphK1) inhibitor N,N-dimethylsphingosine (DMS) in combination with chemotherapeutic drugs (DDP, 5-Fu, MMC) on the proliferation of gastric cancer cells (SGC7901) in vitro, and to evaluate whether SphK1 inhibitors could be used as synergetic agents in chemotherapy."( [Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro].
Hu, CY; Lan, KH; Lu, Q; Tang, W; Wang, SF; Yin, GJ, 2012
)
0.38
" When 1 micromol/L DMS was used in combination with 5-Fu (1, 5, and 25 microg/ml) for 24 h, the growth inhibition rates of the cancer cells were (16."( [Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro].
Hu, CY; Lan, KH; Lu, Q; Tang, W; Wang, SF; Yin, GJ, 2012
)
0.38
"DMS can suppress the proliferation of SGC7901 cells in vitro, and there are evident synergetic effects when it is used in combination with chemotherapeutic drugs."( [Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro].
Hu, CY; Lan, KH; Lu, Q; Tang, W; Wang, SF; Yin, GJ, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Identical dose-response curves are obtained for the Ca2+ release stimulated by cross-linking FcgammaRIIA, implicating these two enzymes in a common signaling pathway."( Convergence of Fc gamma receptor IIA and Fc gamma receptor IIIB signaling pathways in human neutrophils.
Chuang, FY; Sassaroli, M; Unkeless, JC, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 2.7.1.91 (sphingosine kinase) inhibitorAn EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor that interferes with the action of sphinganine kinase (EC 2.7.1.91).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
aminodiolAn amino alcohol having two hydroxy functional groups.
sphingoidSphinganine, its homologs and stereoisomers, and the hydroxy and unsaturated derivatives of these compounds.
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Lethal factorBacillus anthracisIC50 (µMol)2.30000.09702.85976.0000AID406412
Sphingosine kinase 2Homo sapiens (human)IC50 (µMol)42.09670.35603.535210.0000AID1306032; AID1478823; AID420342
Sphingosine kinase 2Homo sapiens (human)Ki12.83330.00368.805210.0000AID1151446; AID1306028; AID374894
Sphingosine kinase 1Homo sapiens (human)IC50 (µMol)24.82600.00081.30397.1000AID1306031; AID1478822; AID374895; AID420341; AID439083
Sphingosine kinase 1Homo sapiens (human)Ki9.00000.00363.095610.0000AID1151445; AID1306027; AID374893
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (59)

Processvia Protein(s)Taxonomy
blood vessel developmentSphingosine kinase 2Homo sapiens (human)
positive regulation of cytokine production involved in immune responseSphingosine kinase 2Homo sapiens (human)
sphingosine-1-phosphate receptor signaling pathwaySphingosine kinase 2Homo sapiens (human)
sphinganine-1-phosphate biosynthetic processSphingosine kinase 2Homo sapiens (human)
sphingosine metabolic processSphingosine kinase 2Homo sapiens (human)
brain developmentSphingosine kinase 2Homo sapiens (human)
cell population proliferationSphingosine kinase 2Homo sapiens (human)
positive regulation of cell population proliferationSphingosine kinase 2Homo sapiens (human)
sphingolipid biosynthetic processSphingosine kinase 2Homo sapiens (human)
negative regulation of cell growthSphingosine kinase 2Homo sapiens (human)
positive regulation of interleukin-13 productionSphingosine kinase 2Homo sapiens (human)
positive regulation of interleukin-6 productionSphingosine kinase 2Homo sapiens (human)
positive regulation of tumor necrosis factor productionSphingosine kinase 2Homo sapiens (human)
positive regulation of mast cell activation involved in immune responseSphingosine kinase 2Homo sapiens (human)
positive regulation of apoptotic processSphingosine kinase 2Homo sapiens (human)
regulation of canonical NF-kappaB signal transductionSphingosine kinase 2Homo sapiens (human)
positive regulation of mast cell degranulationSphingosine kinase 2Homo sapiens (human)
transcription initiation-coupled chromatin remodelingSphingosine kinase 2Homo sapiens (human)
sphingosine biosynthetic processSphingosine kinase 2Homo sapiens (human)
positive regulation of protein kinase C signalingSphingosine kinase 2Homo sapiens (human)
positive regulation of calcium ion importSphingosine kinase 2Homo sapiens (human)
regulation of reactive oxygen species biosynthetic processSphingosine kinase 2Homo sapiens (human)
cellular response to phorbol 13-acetate 12-myristateSphingosine kinase 2Homo sapiens (human)
regulation of cytochrome-c oxidase activitySphingosine kinase 2Homo sapiens (human)
positive regulation of ceramide biosynthetic processSphingosine kinase 2Homo sapiens (human)
regulation of ATP biosynthetic processSphingosine kinase 2Homo sapiens (human)
phosphorylationSphingosine kinase 2Homo sapiens (human)
negative regulation of apoptotic processSphingosine kinase 1Homo sapiens (human)
positive regulation of fibroblast proliferationSphingosine kinase 1Homo sapiens (human)
blood vessel developmentSphingosine kinase 1Homo sapiens (human)
sphingosine-1-phosphate receptor signaling pathwaySphingosine kinase 1Homo sapiens (human)
protein acetylationSphingosine kinase 1Homo sapiens (human)
sphingosine metabolic processSphingosine kinase 1Homo sapiens (human)
inflammatory responseSphingosine kinase 1Homo sapiens (human)
brain developmentSphingosine kinase 1Homo sapiens (human)
cell population proliferationSphingosine kinase 1Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationSphingosine kinase 1Homo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathwaySphingosine kinase 1Homo sapiens (human)
phosphorylationSphingosine kinase 1Homo sapiens (human)
calcium-mediated signalingSphingosine kinase 1Homo sapiens (human)
regulation of endocytosisSphingosine kinase 1Homo sapiens (human)
sphingolipid biosynthetic processSphingosine kinase 1Homo sapiens (human)
positive regulation of cell growthSphingosine kinase 1Homo sapiens (human)
positive regulation of cell migrationSphingosine kinase 1Homo sapiens (human)
positive regulation of protein ubiquitinationSphingosine kinase 1Homo sapiens (human)
regulation of interleukin-1 beta productionSphingosine kinase 1Homo sapiens (human)
positive regulation of interleukin-17 productionSphingosine kinase 1Homo sapiens (human)
response to tumor necrosis factorSphingosine kinase 1Homo sapiens (human)
intracellular signal transductionSphingosine kinase 1Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusSphingosine kinase 1Homo sapiens (human)
negative regulation of apoptotic processSphingosine kinase 1Homo sapiens (human)
positive regulation of angiogenesisSphingosine kinase 1Homo sapiens (human)
positive regulation of mitotic nuclear divisionSphingosine kinase 1Homo sapiens (human)
positive regulation of mitotic cell cycleSphingosine kinase 1Homo sapiens (human)
positive regulation of smooth muscle contractionSphingosine kinase 1Homo sapiens (human)
sphingosine biosynthetic processSphingosine kinase 1Homo sapiens (human)
sphingoid catabolic processSphingosine kinase 1Homo sapiens (human)
regulation of phagocytosisSphingosine kinase 1Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activitySphingosine kinase 1Homo sapiens (human)
cellular response to hydrogen peroxideSphingosine kinase 1Homo sapiens (human)
DNA biosynthetic processSphingosine kinase 1Homo sapiens (human)
regulation of neuroinflammatory responseSphingosine kinase 1Homo sapiens (human)
negative regulation of ceramide biosynthetic processSphingosine kinase 1Homo sapiens (human)
positive regulation of p38MAPK cascadeSphingosine kinase 1Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionSphingosine kinase 1Homo sapiens (human)
regulation of microglial cell activationSphingosine kinase 1Homo sapiens (human)
regulation of endosomal vesicle fusionSphingosine kinase 1Homo sapiens (human)
cellular response to growth factor stimulusSphingosine kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
lipid kinase activitySphingosine kinase 2Homo sapiens (human)
protein bindingSphingosine kinase 2Homo sapiens (human)
ATP bindingSphingosine kinase 2Homo sapiens (human)
sphinganine kinase activitySphingosine kinase 2Homo sapiens (human)
D-erythro-sphingosine kinase activitySphingosine kinase 2Homo sapiens (human)
small GTPase bindingSphingosine kinase 2Homo sapiens (human)
sphingosine-1-phosphate receptor activitySphingosine kinase 2Homo sapiens (human)
histone bindingSphingosine kinase 2Homo sapiens (human)
magnesium ion bindingSphingosine kinase 1Homo sapiens (human)
lipid kinase activitySphingosine kinase 1Homo sapiens (human)
DNA bindingSphingosine kinase 1Homo sapiens (human)
protein bindingSphingosine kinase 1Homo sapiens (human)
calmodulin bindingSphingosine kinase 1Homo sapiens (human)
ATP bindingSphingosine kinase 1Homo sapiens (human)
lipid bindingSphingosine kinase 1Homo sapiens (human)
sphinganine kinase activitySphingosine kinase 1Homo sapiens (human)
acetyltransferase activitySphingosine kinase 1Homo sapiens (human)
D-erythro-sphingosine kinase activitySphingosine kinase 1Homo sapiens (human)
sphingosine-1-phosphate receptor activitySphingosine kinase 1Homo sapiens (human)
protein phosphatase 2A bindingSphingosine kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
nucleusSphingosine kinase 2Homo sapiens (human)
nucleoplasmSphingosine kinase 2Homo sapiens (human)
cytoplasmSphingosine kinase 2Homo sapiens (human)
mitochondrionSphingosine kinase 2Homo sapiens (human)
mitochondrial inner membraneSphingosine kinase 2Homo sapiens (human)
lysosomal membraneSphingosine kinase 2Homo sapiens (human)
endoplasmic reticulumSphingosine kinase 2Homo sapiens (human)
cytosolSphingosine kinase 2Homo sapiens (human)
membraneSphingosine kinase 2Homo sapiens (human)
nucleosomeSphingosine kinase 2Homo sapiens (human)
intracellular membrane-bounded organelleSphingosine kinase 2Homo sapiens (human)
membraneSphingosine kinase 2Homo sapiens (human)
cytoplasmSphingosine kinase 2Homo sapiens (human)
presynapseSphingosine kinase 1Homo sapiens (human)
nucleusSphingosine kinase 1Homo sapiens (human)
nucleoplasmSphingosine kinase 1Homo sapiens (human)
cytoplasmSphingosine kinase 1Homo sapiens (human)
cytosolSphingosine kinase 1Homo sapiens (human)
plasma membraneSphingosine kinase 1Homo sapiens (human)
clathrin-coated pitSphingosine kinase 1Homo sapiens (human)
endocytic vesicleSphingosine kinase 1Homo sapiens (human)
early endosome membraneSphingosine kinase 1Homo sapiens (human)
presynapseSphingosine kinase 1Homo sapiens (human)
intracellular membrane-bounded organelleSphingosine kinase 1Homo sapiens (human)
membraneSphingosine kinase 1Homo sapiens (human)
cytoplasmSphingosine kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (54)

Assay IDTitleYearJournalArticle
AID374896Effect on EGFP-fused human SPHK1 activity expressed in CHO cells at 10 uM relative to basal level2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID374892Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID401376Antimicrobial activity against Oscillatoria amphibia at 5 ppm1998Journal of natural products, Jun-26, Volume: 61, Issue:6
New ceramide from marine sponge Haliclona koremella and related compounds as antifouling substances against macroalgae.
AID1478823Inhibition of recombinant human SphK2 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method2017Bioorganic & medicinal chemistry, 06-15, Volume: 25, Issue:12
Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure-activity relationship study of 4-epi-jaspine B.
AID1627822Induction of vacuolation in mouse FL5.12A cells assessed as vacuolation score at 2.5 uM measured at 3 hrs by fluorescence microscopic analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cell death.
AID374899Inhibition of TNF-alpha-induced sphingosine-1-phosphate levels in human U937 cells at 5 uM after 2 hrs by ELISA2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID614541Inhibition of N-terminal GST-fused PKCalpha (1-672) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID374893Inhibition of EGFP-fused human SPHK1 expressed in CHO cells using D-erythro-sphingosine as substrate by Michaelis-Menten plot2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID614532Inhibition of N-terminal GST-fused PKCepsilon (1-737) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID406412Protection against Bacillus anthracis lethal toxin-mediated cytotoxicity in mouse RAW264.7 cells assessed as change in viability after 24 hrs by WST1 dye reduction assay2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
AID401373Antimicrobial activity against Prorocentrum micans at 5 ppm1998Journal of natural products, Jun-26, Volume: 61, Issue:6
New ceramide from marine sponge Haliclona koremella and related compounds as antifouling substances against macroalgae.
AID401372Antimicrobial activity against Branchiomonas submaria at 5 ppm1998Journal of natural products, Jun-26, Volume: 61, Issue:6
New ceramide from marine sponge Haliclona koremella and related compounds as antifouling substances against macroalgae.
AID1151446Inhibition of SphK2 (unknown origin)2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
AID1306032Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice.
AID374901Inhibition of human SPHK2 expressed in human U937 cells assessed as inhibition of endogenous sphingosine-1-phosphate levels at 5 uM after 2 hrs by ELISA2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID374895Inhibition of EGFP-fused human SPHK1 expressed in CHO cells2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID374905Inhibition of human PKCalpha at 50 uM by gel electrophoresis2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID614534Inhibition of N-terminal GST-fused PKCeta (1-683) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID614530Inhibition of N-terminal GST-fused PKCgamma (1-697) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID406410Protection against Bacillus anthracis protective antigen and lethal toxin-diphtheria toxin chimeric protein mediated cytotoxicity in mouse RAW264.7 cells assessed as cell viability2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
AID1627820Cytotoxicity against mouse FL5.12A cells after 48 hrs by DAPI staining-based flow cytometric analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cell death.
AID374897Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID614542Inhibition of N-terminal GST-fused PKCbeta1 (1-671) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID1306027Inhibition of His-tagged full length human recombinant SPHK1 expressed in baculovirus infected fall armyworm Sf9 cell expression system using sphingosine as substrate by ADP-quest assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice.
AID614543Inhibition of N-terminal GST-fused PKCbeta2 (1-673) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID1151445Inhibition of SphK1 (unknown origin)2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
AID401370Antifouling activity against Ulva conglobata spores assessed as germination and attachment rate at 5 ppm1998Journal of natural products, Jun-26, Volume: 61, Issue:6
New ceramide from marine sponge Haliclona koremella and related compounds as antifouling substances against macroalgae.
AID374891Inhibition of EGFP-fused human SPHK1 expressed in CHO cells at 10 uM2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID1306028Inhibition of His-tagged full length human recombinant SPHK2 expressed in baculovirus infected fall armyworm Sf9 cell expression system using sphingosine as substrate by ADP-quest assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice.
AID420341Inhibition of SphK12009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.
AID374894Inhibition of human cloned SPHK2 expressed in CHO cells using D-erythro-sphingosine as substrate by Michaelis-Menten plot2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID614533Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID439083Inhibition of human sphingosine kinase 1 by off chip mobility shift assay2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Discovery of novel sphingosine kinase 1 inhibitors.
AID614536Inhibition of N-terminal GST-fused PKCzeta (1-592) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID374898Inhibition of basal sphingosine-1-phosphate levels in human U937 cells at 5 uM after 2 hrs by ELISA2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID406411Protection against Bacillus anthracis lethal toxin-mediated cytotoxicity in mouse RAW264.7 cells assessed as change in viability at 0.125 to 12.5 uM relative to toxin-treated control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
AID204181Inhibitory activity against sphingosine kinase expressed in HEK293 cells at 10 uM1999Bioorganic & medicinal chemistry letters, Nov-01, Volume: 9, Issue:21
Structure-activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase.
AID614540Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID1306031Inhibition of GST-tagged full length human recombinant SPHK1 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice.
AID401374Antimicrobial activity against Skeletonema costatum at 5 ppm1998Journal of natural products, Jun-26, Volume: 61, Issue:6
New ceramide from marine sponge Haliclona koremella and related compounds as antifouling substances against macroalgae.
AID374900Inhibition of human SPHK1 expressed in human U937 cells assessed as inhibition of endogenous sphingosine-1-phosphate levels at 5 uM after 2 hrs by ELISA2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
AID1478822Inhibition of recombinant human SphK1 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method2017Bioorganic & medicinal chemistry, 06-15, Volume: 25, Issue:12
Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure-activity relationship study of 4-epi-jaspine B.
AID439084Inhibition of sphingosine kinase 2 at 10 uM2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Discovery of novel sphingosine kinase 1 inhibitors.
AID614535Inhibition of N-terminal GST-fused PKCtheta (1-706) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID1627821Downregulation of CD98 expression level in mouse FL5.12A cells at 2.5 uM measured at 3 hrs by flow cytometric analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cell death.
AID614539Inhibition of N-terminal GST-fused sphingosine kinase 1 (1-384) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID420342Inhibition of SphK22009Bioorganic & medicinal chemistry letters, Jul-01, Volume: 19, Issue:13
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.
AID614531Inhibition of N-terminal GST-fused PKCdelta (1-676) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (163)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.61)18.7374
1990's34 (20.86)18.2507
2000's83 (50.92)29.6817
2010's41 (25.15)24.3611
2020's4 (2.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.51 (24.57)
Research Supply Index5.11 (2.92)
Research Growth Index6.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.21%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other163 (98.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]